跳至主要内容
临床试验/ISRCTN58235785
ISRCTN58235785已完成不适用

Barrett’s oesophagus surveillance with optical biopsy using spectroscopy and enhanced endoscopic imaging to target high-risk lesions: a prospective cohort study

CL Biomedical Research Unit0 个研究点目标入组 2,000 人开始时间: 2016年9月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
2,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Patients will be recruited from those with Barrett’s oesophagus with or without other alterations (low-grade dysplasia [LGD] or high-grade dysplasia [HGD], any oesophageal or gastric cancer) undergoing endoscopy
  • 2. Patients without Barrett’s oesophagus attending for a clinically indicated endoscopy may be recruited as controls
  • 3. Patients must sign an informed consent form

排除标准

  • 1. Patients in whom endoscopy and biopsy is contraindicated
  • 2. Patients who are unable to give informed consent
  • 3. Pregnant women
  • 4. People under the age of 21 years
  • 5. People who are non-English speakers

研究者

发起方
CL Biomedical Research Unit

相似试验